Literature DB >> 6688019

Reversal of atracurium with edrophonium.

W L Baird, W J Kerr.   

Abstract

The antagonistic action of a bolus dose of edrophonium 0.75 mg kg-1 on the neuromuscular blockade induced by atracurium was studied in 10 patients anaesthetized with nitrous oxide and narcotic supplements. The reversal agent was administered when the twitch height had recovered spontaneously to approximately 20% of control. Twitch response was restored to 100% of control after 4.7 +/- 2.2 min. Clinically adequate reversal (train-of-four ratio of 75% or better) was achieved 6.6 +/- 1.5 min following injection of the edrophonium and there was no evidence of subsequent muscle weakness. The possible advantages of the clinical use of edrophonium in producing a rapid reversal of atracurium blockade are discussed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6688019

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  3 in total

Review 1.  A simulation of neuromuscular function and heart rate during induction, maintenance, and reversal of neuromuscular blockade.

Authors:  R R Jaklitsch; D R Westenskow
Journal:  J Clin Monit       Date:  1990-01

Review 2.  New intravenous anaesthetics and neuromuscular blocking drugs. A review of their properties and clinical use.

Authors:  C S Reilly; W S Nimmo
Journal:  Drugs       Date:  1987-07       Impact factor: 9.546

3.  Accelerated reversal of atracurium blockade with divided doses of neostigmine.

Authors:  M Abdulatif; M Naguib
Journal:  Can Anaesth Soc J       Date:  1986-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.